Health
COVID vaccines focus on the spike protein – but here’s another target – The Conversation UK
New research shows why the N protein might be a good target.
The latest results from the phase 3 COVID-19 vaccines trials have been very positive. These have shown that vaccinating people with the gene for SARS-CoV-2 spike protein can induce excellent protective immunity.
The spike protein is the focus of most COVID-19 vaccines as it is the part of the virus that enables it to enter our cells. Virus replication only happens inside cells, so blocking entry prevents more virus being made. If a person has antibodies that can recognise the spike protein, this…
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
General22 hours agoReserve Bank board still looking for yesterday’s news
-
Noosa News17 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News22 hours agoEric Bana Is Back in Murder-Mystery Mode (and in Scenic Surroundings) in the Trailer for New Netflix Series ‘Untamed’